Novartis CEO: Let’s assume we launch the product in markets where we can comply with Most Favored Nation (MFN) policies, while in other markets we will have to postpone the launch.
2026-11-19
Novartis CEO: Let’s assume we launch the product in markets where we can comply with Most Favored Nation (MFN) policies, while in other markets we will have to postpone the launch.